Close Menu

What Is It?

PolITiGenomics's David Dooling wonders just what Illumina's GA IIe is. He notes that the IIe is cheaper than the GA IIx and is supposed to produce half as much data as the IIx, but the optics should be about the same since the run times are similar and both machines use the same reagent kits. "If reagent costs are indeed the same, it makes no sense to buy two GA IIe instruments. You would be much better off buying one GA IIx," Dooling blogs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.